40th Congress of the International Society of Oncology and Biomarkers (ISOBM) (ISOBM Annual Meeting)

Venue: Ramada Jerusalem Hotel

Location: Jerusalem, 91033, Israel

Event Date/Time: Oct 14, 2012 End Date/Time: Oct 17, 2012
Abstract Submission Date: Jul 15, 2012
Report as Spam

Description

Scientific program:



TUMOR CELLS BIOLOGY

     EPIGENETICS

     IMMUNOLOGY of CANCER

     PRECLINICAL IMMUNOTHERAPY

     MICROENVIRONMENT: Stromal Epithelial interactions

     TUMOR HETEROGENEITY

     METASTASIS / MICRO—METASTASIS

     P-53 ROLE IN CANCER

     VEGF - ROLE IN CANCER & ANTI VEGF THERAPIES



BIOMARKERS

     CLINICAL UTILITY

     THERAPY RESPONSE ASSESSMENT

     PROGNOSIS and PREDICTION (In ROUTINE ONCOLOGY& CLINICAL

TRIALS)

     GUIDELINES

     VALIDATION AND STATISTICS



CANCER STEM CELLS, CIRCULATING TUMOR CELLS



NEW EMERGING THERAPY TARGETS:

     ORC1 / 2 Inhibitors

     DII4 Inhibitors

     JAK /STATS

     MEK Inhibitors

     Src Inhibitors

     NOTCH and WNT Inhibitors

     PARP Inhibitors

     Anti IGF-1R

     B-RAF in Melanoma



BREAST CANCER

     EPIDEMIOLOGY, RISKS, ENVIRONMENTAL EXPOSURE

     EARLY DETECTION

     IMAGING

     GENETICS and PREVENTION

     HER-2 Evaluation (Pathology & Serum)



     NEW TREATMENTS:

     Immunotherapy, HER-2 targeted therapy, Anti -Angiogenic

Therapy, Alternative therapies, Combinations



OVARIAN CANCER

     EARLY DETECTION

     GENETICS of OVARIAN CANCER

     BIOMARKERS: ROMA + HE-4 +CA125 and others.

     NEW TREATMENTS



UROLOGICAL CANCER (PROSTATE, BLADDER)

     EARLY DETECTION

     BIOMARKERS

     RESPONSE TO TREATMENTS

     EARLY DETECTION OF RECURRENCE

     NEW TREATMENTS



GASTROINTESTINAL CANCER

     EARLY DETECTION

     PREVENTION

     NEW TUMOR MARKERS

     NEW TREATMENTS



LUNG CANCER

     EPIDEMIOLOGY

     PREVENTION

     EARLY DETECTION

     NEW BIOMARKERS

     NEW TREATMENTS



MELANOMA

     EPIDEMIOLOGY

     PREVENTION

     EARLY DETECTION

     NEW BIOMARKERS FOR:

     EVALUATION of TREATMENT RESPONSE

     RECCURENCE EARLIER DETECTION

     NEW TREATMENTS (Immunotherapies, Vaccines, Target Ab)




LEUKEMIA & LYMPHOMA

Venue

Ruppin Bridge at Herzl Blvd
Israel
MORE INFO ON THIS VENUE